Tech Company Financing Transactions
Flindr Therapeutics Funding Round
V-Bio Ventures, Curie Capital and Flanders Future Techfund participated in a $21.4 million Series A funding round for Flindr Therapeutics. The round was announced on 4/24/2024.
Transaction Overview
Company Name
Announced On
4/24/2024
Transaction Type
Venture Equity
Amount
$21,400,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to progress its lead program to IND, develop an exciting second program, and broaden its pipeline using the ImmunoGram Drug Discovery Engine.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
Oss, Undisclosed
The Netherlands
Oss, Undisclosed
The Netherlands
Phone
Undisclosed
Website
Email Address
Overview
Flindr Therapeutics, based in Oss in the Netherlands, is a private pre-clinical biotech company developing next-generation precision oncology treatments. The Company, previously called Immagene, was spun out of the Netherlands Cancer Institute (NKI) and Oncode Institute in 2020, by founders Prof Daniel Peeper, Prof Christian Blank and Dr Maarten Ligtenberg.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maarten Ligtenberg
Browse more venture capital transactions:
Prev: 4/24/2024: Salesforge venture capital transaction
Next: 4/24/2024: Arab Therapy venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs